When comparing CRC tumors with lower CD8+ T cell density (categories 1 and 2), samples in category 2 characterized by high MTO show down-regulation of pathways mainly related to T cell differentiation, T cell activation and pro-inflammatory cytokine and chemokine release (Figures 4E, F). This evidence concerns the gene CD8A and colorectal carcinoma.